Chemoinformaics analysis of N-METHOXY-1-VINYL-BETA-CARBOLINE
| Molecular Weight | 224.263 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.167 | nRig | 16 |
| Exact Molecular Weight | 224.095 | nRing | 3 |
| Solubility: LogS | -3.935 | nHRing | 2 |
| Solubility: LogP | 2.779 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 15 |
| nHA | 3 | APOL | 34.3835 |
| nHD | 0 | BPOL | 15.4845 |
| QED | 0.669 |
| Synth | 2.789 |
| Natural Product Likeliness | 0.371 |
| NR-PPAR-gamma | 0.917 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.185 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.597 |
| MDCK | 0.0000262 |
| BBB | 0.943 |
| PPB | 0.930038 |
| VDSS | 0.827 |
| FU | 0.03593 |
| CYP1A2-inh | 0.993 |
| CYP1A2-sub | 0.86 |
| CYP2c19-inh | 0.717 |
| CYP2c19-sub | 0.815 |
| CYP2c9-inh | 0.564 |
| CYP2c9-sub | 0.737 |
| CYP2d6-inh | 0.395 |
| CYP2d6-sub | 0.901 |
| CYP3a4-inh | 0.317 |
| CYP3a4-sub | 0.563 |
| CL | 4.863 |
| T12 | 0.452 |
| hERG | 0.031 |
| Ames | 0.964 |
| ROA | 0.238 |
| SkinSen | 0.115 |
| Carcinogencity | 0.93 |
| EI | 0.952 |
| Respiratory | 0.72 |
| NR-Aromatase | 0.892 |
| Antiviral | No |
| Prediction | 0.661704 |